ATG-037, an oral small molecule CD73 inhibitor, in combination with MSD's anti-PD-1 therapy, KEYTRUDA® (pembrolizumab), achieved an overall response rate (ORR)...

CAMBRIDGE, Mass., May 23, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND"...

This modular tool features 10+ accessories designed to meet diverse needs such as a jet fan, handheld fan, camping light,...

SHANGHAI, May 23, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the...

YOKOHAMA, Japan, May 22, 2025 /PRNewswire/ -- May 21–23, 2025,ThunderSoft, a global leader in intelligent automotive software, made its debut at...

Phase 1/2 first-in-human clinical study planned this year SHANGHAI and SAN DIEGO, May 23, 2025 /PRNewswire/ -- Duality Biotherapeutics ("DualityBio",...

SYDNEY, May 23, 2025 /PRNewswire/ -- Kicking off Momentum 2025,  Manhattan Associates Inc. (NASDAQ: MANH) today announced sweeping Agentic AI support within Manhattan...

BEIJING, May 23, 2025 /PRNewswire/ -- A news report from Xinhuanet: A new publication highlighting the appearance of Chinese-built infrastructure on...

BEIJING, May 23, 2025 /PRNewswire/ -- On the crown of global agricultural heritage, a new jewel has been added. On May...

ISLAMABAD, May 23, 2025 /PRNewswire/ -- In a groundbreaking move to elevate clinical diagnostics nationwide, MindHYVE.ai™, a U.S.-based pioneer in...